Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for Insulin Sensitivity in Obese Individuals
NCT00928876Phase 2Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2009
- Primary completion
- Mar 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in insulin resistance (IR), obesity and metabolic syndrome comparing Anakinra Sequence with Placebo Sequence (2 arms). Primary endpoint: Insulin sensitivity measured by euglycemic hyperinsulinemic clamp at 4 weeks. Status: unknown.
02
Drugs
anakinra
03
Conditions
insulin resistance (IR)obesitymetabolic syndrome
Beyond the preview
Go deeper on NCT00928876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928876.